In his Q4 letter to investors, Third Point's Dan Loeb outlines his thesis for taking a stake in...
In his Q4 letter to investors, Third Point's Dan Loeb outlines his thesis for taking a stake in Herbalife (HLF). Loeb points out that the research his firm conducted showed no evidence of any pyramid scheme, and the beating the stock took at the hands of Ackman created an attractive entry point to buy the shares. By applying a modest 10-12x earnings multiple, Loeb suggests the stock's worth between $55 - 68 per share - translating to 40% - 70% upside from current levels.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Mon, 8:49AM)
at Zacks.com (Fri, 9:15AM)
at CNBC.com (Thu, 5:24PM)
at CNBC.com (Thu, 5:06PM)
at Benzinga.com (Thu, 5:03PM)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs